Alan Seth Krasner insider trades: Crinetics Pharmaceuticals (CRNX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Alan reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 17, 2023 | CRNX | ↓ Sell | 7,000 | $30.00 | $210K | Direct | Oct 19, 2023 (2d) |
| Jan 19, 2022 | CRNX | ↓ Sell | 6,700 | $21.21 | $142K | Direct | Jan 21, 2022 (2d) |
| Jul 20, 2018 | CRNX | ↑ Buy | 2,000 | $17.00 | $34K | Direct | Jul 20, 2018 (0d) |
| Nov 2, 2012 | BIOD | ↓ Sell10b5-1 | 3,500 | $2.81 | $10K | Direct | Nov 5, 2012 (3d) |
| Sep 20, 2011 | BIOD | ↓ Sell | 3,855 | $1.17 | $5K | Direct | Sep 22, 2011 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRNX insiders
Open-market trades in the last 12 months
About Alan Seth Krasner's insider trades
Alan Seth Krasner is Chief Medical Officer at Crinetics Pharmaceuticals (CRNX). Since Sep 20, 2011, Alan has reported 1 open-market purchase worth $34K and 4 sales worth $366K on SEC Form 4. There have been no open-market trades in the last 12 months.
1 sale (3% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.
Their filings also include grants and awards (14 filings), option exercises (8 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRNX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.